Lipid-based nanoparticle technologies for liver targeting

R Böttger, G Pauli, PH Chao, NAL Fayez… - Advanced drug delivery …, 2020 - Elsevier
Liver diseases such as hepatitis, cirrhosis, and hepatocellular carcinoma are global health
problems accounting for approximately 800 million cases and over 2 million deaths per year …

Development and characterization of the solvent-assisted active loading technology (SALT) for liposomal loading of poorly water-soluble compounds

G Pauli, WL Tang, SD Li - Pharmaceutics, 2019 - mdpi.com
A large proportion of pharmaceutical compounds exhibit poor water solubility, impacting
their delivery. These compounds can be passively encapsulated in the lipid bilayer of …

[HTML][HTML] Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis

G Ye, Q Yang, X Lei, X Zhu, F Li, J He, H Chen… - Theranostics, 2020 - ncbi.nlm.nih.gov
Rationale: Peritoneal metastasis predicts poor prognosis of gastric cancer (GC) patients,
and the underlying mechanisms are poorly understood. Methods: The 2-DIGE, MALDI …

DOX/ICG coencapsulated liposome-coated thermosensitive nanogels for NIR-triggered simultaneous drug release and photothermal effect

L Yu, A Dong, R Guo, M Yang, L Deng… - … Biomaterials Science & …, 2018 - ACS Publications
Chemo-photothermal therapy has shown enormous potential in treating cancer. To achieve
the chemo-photothermal synergistic effect, an efficient nanoparticulate system with the ability …

Liposome-based probes for molecular imaging: from basic research to the bedside

Y **a, C Xu, X Zhang, P Ning, Z Wang, J Tian, X Chen - Nanoscale, 2019 - pubs.rsc.org
Molecular imaging is very important in disease diagnosis and prognosis. Liposomes are
excellent carriers for different types of molecular imaging probes. In this work, we summarize …

Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy

H Zhang, WL Tang, A Kheirolomoom, BZ Fite… - Journal of Controlled …, 2021 - Elsevier
Resiquimod (R848) is a toll-like receptor 7 and 8 (TLR7/8) agonist with potent antitumor and
immunostimulatory activity. However, systemic delivery of R848 is poorly tolerated because …

Recent advances in applying nanotechnologies for cancer immunotherapy

R Mahjub, S Jatana, SE Lee, Z Qin, G Pauli… - Journal of controlled …, 2018 - Elsevier
Cancer immunotherapy aimed at boosting cancer-specific immunoresponses to eradicate
tumor cells has evolved as a new treatment modality. Nanoparticles incorporating antigens …

Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery

WL Tang, WH Tang, A Szeitz, J Kulkarni, P Cullis, SD Li - Biomaterials, 2018 - Elsevier
The solvent-assisted active loading technology (SALT) was developed for encapsulating a
water insoluble weak base into the liposomal core in the presence of 5% DMSO. In this …

Cancer theranostic applications of lipid-based nanoparticles

WL Tang, WH Tang, SD Li - Drug Discovery Today, 2018 - Elsevier
Highlights•LNPs can be doped with multiple components for theranostics.•LNPs allow
versatile multimodal imaging and therapy of cancer.•LNPs empower image-guided drug …

Rebamipide liposome as an effective ocular delivery system for the management of dry eye disease

H Qiao, Z Xu, M Sun, S Fu, F Zhao, D Wang… - Journal of Drug Delivery …, 2022 - Elsevier
Dry eye disease (DED) is a public health concern that cause ocular discomfort and visual
disturbance, which seriously affect quality of life. Rebamipide (RBM) is one of the drugs …